Module Database Search
| MODULE DESCRIPTOR | |||
|---|---|---|---|
| Module Title | |||
| Rational Drug Design | |||
| Reference | PL2002 | Version | 3 |
| Created | February 2023 | SCQF Level | SCQF 8 |
| Approved | June 2022 | SCQF Points | 30 |
| Amended | September 2023 | ECTS Points | 15 |
| Aims of Module | |||
|---|---|---|---|
| To develop an understanding of the structure and properties of drugs and identify a link to their pharmacological properties. | |||
| Learning Outcomes for Module | |
|---|---|
| On completion of this module, students are expected to be able to: | |
| 1 | Discuss the origins, structures and properties of pharmacologically important compounds and apply the principles of rational drug design to selected classes of drugs. |
| 2 | Manipulate, interpret and evaluate experimental data. |
| 3 | Discuss procedures for the synthesis, extraction, isolation, characterisation and/or quantification of molecules of biological importance. |
| Indicative Module Content |
|---|
| Topics include: Drug discovery, drug targeting, mechanisms of drug action and elements of xenobiotic metabolism. |
| Module Delivery |
|---|
| Lectures, coursework sessions (individual and group practicals, tutorials and online activities) and directed study activities. |
| Indicative Student Workload | Full Time | Part Time |
|---|---|---|
| Contact Hours | 85 | N/A |
| Non-Contact Hours | 215 | N/A |
| Placement/Work-Based Learning Experience [Notional] Hours | N/A | N/A |
| TOTAL | 300 | N/A |
| Actual Placement hours for professional, statutory or regulatory body |
| ASSESSMENT PLAN | |||||
|---|---|---|---|---|---|
| If a major/minor model is used and box is ticked, % weightings below are indicative only. | |||||
| Component 1 | |||||
| Type: | Examination | Weighting: | 100% | Outcomes Assessed: | 1, 2, 3 |
| Description: | Component 1 is a written exam. | ||||
| MODULE PERFORMANCE DESCRIPTOR | |
|---|---|
| Explanatory Text | |
| Component 1 (EX1 ) comprises 100% of the module grade. A minimum of a Grade D is required to pass the module. | |
| Module Grade | Minimum Requirements to achieve Module Grade: |
| A | A |
| B | B |
| C | C |
| D | D |
| E | E |
| F | F |
| NS | Non-submission of work by published deadline or non-attendance for examination |
| Module Requirements | |
|---|---|
| Prerequisites for Module | Successful completion of MPharm Stage 1 or equivalent. |
| Corequisites for module | None. |
| Precluded Modules | None. |
| INDICATIVE BIBLIOGRAPHY | |
|---|---|
| 1 | PATRICK, G.L., 2017. An Introduction to Medicinal Chemistry. Sixth edition. Oxford: Oxford University Press. |
| 2 | BRUICE, P.Y., 2016. Essential Organic Chemistry. Third edition. London: Pearson Education Ltd. |
| 3 | McMURRY, J., 2007. Fundamentals of general, organic, and biological chemistry. Fifth edition. Upper Saddle River, N.J.: Pearson Prentice Hall. |